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ABSTRACT
YB-1 cDNA clones were isolated by binding site
screening of a Hela expression library using a human
papillomavirus type 18 enhancer ollgonucleotlde. YB-1
belongs to a family of transcription factors which bind
to recognition sequences containing a core CCAAT
element. YB-1 bound to its single stranded recognition
sequence on the sense strand but not to the anti-sense
strand. A synthetic peptide antiserum derived from the
predicted YB-1 amino acid sequence identified a 42kD
nuclear protein In immunoblots. A protein with the
same size was detected by binding site blotting
experiments using the HPV18 enhancer oligonucleotide
which bound YB-1. YB-1 gene expression was
restricted in tissues from a human 24 week old fetus.
High levels of YB-1 mRNA were present in heart,
muscle, liver, lung, adrenal gland and the brain, in
contrast, low amounts of YB-1 mRNA were found in
thymus, kidney, bone marrow and spleen. In pancreas,
bladder, stomach and testis YB-1 mRNA could not be
detected by Northern hybridization. Finally, we have
identified four YB-1 related loci in the mouse genome
and have mapped these loci to four different mouse
chromosomes by interspecific backcross analysis.
INTRODUCTION
The CCAAT box is a sequence element which is present in many
gene control regions. Multiple CCAAT box binding proteins
exist: CP1/NFY (1, 2), CP2 (3), CTF/NF1 (4), C/EBP (5), CBF
(6), YB-1/dbpB, dbpA (7, 8) and H1TF2 (9), and sequence
comparison of cDNA clones encoding CP1/NFY (10), CTF/NF1
(11), C/EBP (12), CBF (6), dbpA and YB-1/dbpB (7, 8) shows
that these factors are not derived from one large gene family but
are distinct. A common feature between these factors is the
recognition of CCAAT boxes. CP1/NFY, CP2, and CTF/NF1
bind to consensus sequences (1); CP1/NFY: A/G A/G CCAAT,
CP2: A/G RCCAAT, CTF/NF1: NGCCAAN (half site). CBF
and YB-1/dbpl are also sequence specific DNA binding proteins
recognizing the CCAAT box because mutations in the CCAAT
sequence abolishes DNA binding (6, 7). C/EBP binds to the
CCAAT motif and to a GCAAT motif with high affinity (5).
CTF/NF1 consists of a series of polypeptides ranging in relative
molecular mass (Mr) from 52000 to 66000 (13). The different
CTF/NF1 polypeptides are encoded by multiple messenger RNAs
containing alternative coding regions, apparently as a result of
differential splicing (11). CTF/NF1 are sequence specific
transcription initiation proteins (4, 13) and are also involved in
initiating Adenovirus DNA replication (14). C/EBP is a 42kD
protein (15) which displays several interesting functions: It
activates transcription of genes in the liver and in adipocytes
where it is involved in regulating energy metabolism (16), it is
only expressed in terminally differentiated cells, which are growth
arrested (17) and it is directly involved in inducing terminal
differentiation and growth arrest (17). NFY/CP1 (1,2) binds as
heterodimer to its recognition sequence which was originally
identified in murine major histocompatibility (MHQ class-H gene
promoters (2). The NFY subunits NFY-A and NFY-B are 42kD
and 35kD proteins (10) which are functionally and structurally
related to the Saccharomyces cerevisiae HAP2 and HAP3 gene
products (3, 10). NFY proteins act as transcriptional activators
for various genes (10). CCAAT binding proteins which have not
been characterized in detail are responsible for cell cycle regulated
expression of the human thymidine kinase gene (18), and are
responsible for serum regulated expression of the human heat
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shock (Hsp 70) gene (19). The histone HI gene regulatory region
is characterized by a histone HI subtype specific consensus
element which contains a CCAAT motif. This motif binds a 47kD
protein (H1TF2) which activates HI histone gene transcription
in vitro (9).
YB-1/dbpB has been identified by binding site screening of
lambda gtll expression libraries with a fragment from the
epidermal growth factor receptor gene (EGF) enhancer (8) and
the major histocompatibility complex class-H Y box containing
an inverted CCAAT box (7). Little is known about the function,
tissue type expression and the nature of cellular YB-1 protein.
In the present communication we have addressed some of these
questions. We have identified a YB-1 recognition site in the
human papillomavirus type 18 (HPV18) enhancer. We have
isolated YB-1 cDNA clones with a HPV18 enhancer
oligonucleotide containing this site. We have identified YB-1
protein in Hela cells with a peptide antiserum derived from the
predicted primary aminoacid sequence from YB-1 cDNA. We
have determined the expression of the Yb-1 gene in different
tissues of a human 24 week old fetus. YB-1 cDNA was used
in mouse chromosomal mapping studies that identified four
independent loci on different mouse chromosomes.
MATERIALS AND METHODS
Cell culture and cell lines
Human fibroblasts, Hela and Cgl3 cells (20) were maintained
in Dulbecco's Modified Eagle's Medium (DMEM) supplemented
with 10% fetal calf serum.
Extraction of Nuclear and Cytoplasmic Proteins
Nuclear extracts of human fibroblasts, Hela and Cgl3 cells were
prepared according to our published procedure (21). After
detergent lysis with 0.65% NP40 nuclei were prepared by low
speed centrifugation at 4°C and proteins were eluted with 53OmM
NaCl with slight agitation. For storage the eluates were dialyzed
against a buffer containing 50% glycerol,50mM NaCl, lOmM
Hepes (pH7.9), 0.5mM PMSF and 0.5mM DTT. Protein
concentrations were determined by a colorimetric assay (Biorad)
using serum albumin as a standard. Cytoplasmic proteins were
prepared after cell lysis and removal of nuclei by low speed
centrifugation. Cytoplasmic proteins were dialyzed as described
above for nuclear proteins.
Synthetic oligonucleotides
Single stranded oligonucleotides and the complementary strands
were synthesized on Applied Biosystems DNA synthesizers and
purified by preparative denaturing acrylamide gel electrophoresis.
Full length bands were identified by UV shadowing, excised,
eluted by diffusion in 500mM ammoniumacetate and ethanol
precipitated. To generate double stranded oligonucleotides
complementary strands were annealed at temperatures minus 3°C
below the specific melting points (Tm). Radiolabeled double
stranded oligonucleotides were prepared with polynucleotide
kinase and ^P-gamma ATP. The sequence of HPV18 enhancer
oligonucleotide RP3 has been described (21). The mutant long
Y-box oligonucleotide: 5'-ATTTTTCTGCTGGGCCAAA-
G-3'was selected from a published sequence (7), the position of
the mutated inverted CCAAT motif is underlined.
Binding Site Blotting
Nuclear proteins were size fractionated on 8% SDS
polyacrylamide gels and transferred to nitrocellulose at 150 mA
overnight at room temperature in a horizontal blotting chamber
(TBI) with a buffer containing 192 mM glycine and 25 mM Tris
(pH 8.3). After blotting bound proteins were denatured in situ
by 6 M guanidinium hydrochloride and renatured by sequential
dilution of guanidinium as described (21, 22). Nitrocellulose
membranes were blocked with 5 % nonfat dry milk (Carnation)
for 30 min at room temperature and subsequently incubated with
end labeled double stranded oligonucleotides at 5 x 105 cpm/ml
in the presence of 5 jtg/ml poly(dIdC)(dIdC) as nonspecific
competitor. The buffers for DNA binding and conditions for
washing binding site blots were as described (21).
Electrophoretic mobility shift analysis (EMSA)
EMS A was carried out as described (21). The incubations of
radiolabeled oligonucleotides with YB-1 fusion protein contained
3 /tg IPTG induced E.coli extract and 2.5 /ig poly(dIdC)(dIdC)
as nonspecific competitor. For EMSA oligonucleotides were
incubated with the protein in binding buffer (21), for 25 min at
room temperature and loaded on a low salt polyacrylamide gel
(4% total monomer, 30:1 acrylamide/N,N'-methylenebisacryl-
amide ratio). Electrophoresis was at 11 V/cm for 90 min at room
temperature. Gels were dried and exposed to X ray film
overnight.
Isolation of YB-1 cDNA from a Hela expression library
The Hela expression library in vector lambda gtl 1 was obtained
from P.Angel. The library was plated on square plates (Nunc,
bioassay dish) at a density of 2X105 pfu per plate on E.coli
Y1090 until small plaques appeared, usually 6 - 8 hours after
plating. Fusion proteins were induced by placing an IPTG
(isopropylthiogalactoside) soaked nitrocellulose membrane on top
of the soft agar layer for four hours. Nitrocellulose filters were
denatured and renatured with guanidinium hydrochloride as
described (22). For binding site screening membranes were
blocked with 5% dry milk for 30 min at room temperature and
subsequently incubated with 5X105 cpm/ml radiolabeled RP3
for two hours. Membranes were washed and exposed to X ray
film. All positive signals were plaque purified twice. Lambda
DNAs were prepared from liquid lysates and analyzed after
EcoRI digestion and agarose gel electrophoresis
Induction of /3-galactosidase-YB-l fusion protein
Escherichia coli strain Y1090 was infected with clones lambda
gtll-N4 or lambda gtl 1-N19 and grown at 37°C until partial
lysis was achieved. Isopropyl thiogalactoside (IPTG) was added
to a final concentration of 10 mM, and the incubation was
continued for one hour. Phenylmethylsulfonyl fluoride (PMSF)
was added to a final concentration of 200 /ig/ml, and the
incubation was continued for another 30 min at 37 °C. The
bacteria were centrifuged at 4550 xg for 5 min at 4°C. The
supernatant was used.
Isolation of RNA from fetal and adult tissues
RNA from fetal and adult tissues was isolated in one step by the
guanidinium thiocyanate extraction method (23). For RNA
extraction frozen tissues were pulverized in liquid nitrogen using
a mortar and pestle. Frozen tissue powder was lysed with
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guanidiniumisothiocyanate, filtered through cheesecloth, and
centrifuged over a 5.7M CsCl cushion. The RNA pellet was
solubilized in water and stored frozen.
Northern hybridization
For Northern analysis 5 ng of total RNA per sample were size
separated on 1% agarose gels in the presence of 2.2 M
formaldehyde and transferred with I O X S S C Gene Screen
membranes (Du Pont) and UV crosslinked with a Stratalinker
(Stratagene). Hybridization conditions were 42°C, 50%
formamide, 5xSSC, and 2.5 xlO6 cpmVml of radiolabeled
YB-1 cDNA. For radiolabeling a 1 kB long EcoRI fragment of
clone N4 containing most of the YB-1 open reading frame was
isolated by preparative gel electrophoresis and labeled with
radioactive triphosphates using a random primer labeling kit
(Amersham). The actin probe was radiolabeled as described
above using a human /3-actin cDNA clone.
DNA sequencing and computer analysis
cDNA was excised from lambda gtl 1 phage by EcoRI digestion
and subcloned into pBluescript n KS+ (Stratagene). Sequencing
reactions were performed by double-stranded dideoxynucleotide
sequencing with a T7 sequencing kit (Pharmacia). Sequence
analyses were performed with the programs HUSAR of the
German Cancer Research Center, ANTIGEN and PROSITE. The
consensus sequences used for potential modification sites were
as follows: N-(P)-(ST)-(P) for Asn glycosylation (N-linked
oligosaccharides), (ST)- X -(RK) for protein kinase C, (ST) X (2)-
(DE), for casein kinase 2 (CKII), and G-(EDKRHPYFW)- X (2)-
(STAGCN) for myristylation.
Antipeptide antisera
The peptide RQPREDGNEEDKEN was synthesized and coupled
to KLH (keyhole lympet hemocyanine). Rabbits were immunized
once with peptide-KLH in complete Freunds adjuvant and twice
with peptide-KLH in incomplete Freunds adjuvant. A more detailed
description of this procedure will be published elsewhere (24).
Immunoblotting with anti peptide antisera
Immunoblots were prepared as for binding site blotting without
a guanidinium denature renature cycle. For imunodetection of
YB-1 die blocked membranes were incubated with a 1:200 fold
dilution of the anti-peptide serum in 0.5% dry milk. For the
detection of bound antibodies a second antibody coupled to
alkaline phosphatase (Dianova) was used at a 1:5000 fold dilution.
Interspecific backcross mapping
Interspecific backcross progeny were generated by mating
(C57BL/6J X M.spretus) F, females and C57BL/6J males as
described (25). A total of 205 N2 progeny were obtained; a
random subset of these N2 mice were used to map the Yb-1 loci
(see text for details). DNA isolation, restriction enzyme digestion,
agarose gel electrophoresis, Southern blot transfer and
hybridization were performed essentially as described (26). All
blots were prepared with Zetabind nylon membranes (AMF-
Cuno). The YB-1 probe, a 500 bp EcoRI fragment of cDNA
corresponding to the 3'end of the coding sequence, was labeled
with (alpha 32P) dCTP using a random prime labeling kit
(Amersham). Washing was done to a final stringency of
0.2XSSCP, 0.1% SDS, 65°C. Major fragments of 8.0, 7.4, and
3.5 kb were detected in SphI digested C57BL/6J DNA; major
fragments of 7.2, 6.2, 5.2, 3.7, 3.6 and 2.7 kb were detected
in SphI digested M. spretus DNA. A description of the probes
and RFLP's for the loci used to position the Yb-1 loci in the
interspecific backcross have been reported. These loci include:
ecotropic viral integration site-1 (Evi-J), fibroblast growth factor
basic (Fgjb), and fibrinogen gamma polypeptide (Fgg) on
chromosome 3 (27); transforming growth factor beta-1 (Tgfl>-1)
and glucose phosphate isomerase-1 (Gpi-1) on chromosome 7
(28, 29); metallothionein-1 (Mt-1), E-cadherin (Ecad) and
haptoglobin (Hp) on chromosome 8 (30); and E26 avian leukemia
virus oncogene 5' domain (Ets-1) and thymus cell antigen-1
(Thy-1) on chromosome 9 (31).
Recombination distances were calculated as described (32)
using the computer program SPRETUS MADNESS. Gene order
was determined by minimizing the number of recombination
events required to explain the allele distribution patterns.
RESULTS
Identification of a YB-1 recognition site hi the enhancer of
human papillomavirus type 18 by binding site screening
The enhancer of human papillomavirus type 18 (HPV18) (33)
is characterized by the presence of multiple octamer related
sequence elements binding Oct-1 and a novel octamer binding
protein p92 (21, 34). The oligonucleotide RP3 strongly binding
to p92 was used for binding site screening experiments in an effort
to clone p92 cDNA. A screen of 2 million plaques of a Hela-
lambda gtl 1 expression library yielded 36 positives which were
plaque purified. All 36 clones were related as was shown by
cDNA insert analysis and crosshybridization. Two representative
clones N4 and N19 encode /3-galactosidase fusion proteins with
a molecular weight of approximately 160kD. From the sizes of
the N4 and N19 fusion proteins the molecular weights of the
cloned proteins could be determined as 44kD because the 0-
galactosidase protein has a molecular weight of 116kD. The
inserts of N4 and N19 were sequenced and a computer analysis
revealed that they are 100% identical with the sequence of a
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Fig. 1. Sequence specificity of YB-1 DNA binding. EMSA competition analysis
with the HPV18 YB-1 recognition site present in RP3 and a mutant Y-Box
oligonucleotide. Three ng of an E.coli lysate 1 hour after IPTG induction were
incubated with RP3 (lane 1), and in the presence of 100x(lane 2) and 500xmolar
excess of unlabeledRW (lane 3). Competition with 100x(lane 4) and 500xmotar
excess (lane 5) of double stranded mutant Y-box oligonucleotide. Retarded
RP3:YB-1 DNA:protein complexes and free RP3 are indicated.
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Fig. 2. Selective binding of YB-1 fusion protein to the sense strand of a YB-1
recognition sequence. (A) Binding she blot of YB-1 fusion protein. Bacterial lysate
of clone N4 without induction (—) and 1 hour after induction with IPTG (+).
In each lane 60 /ig bacterial lysate was used. The blot was probed with double
stranded end labeled RP3. (B) Binding site blots as in (A) probed with single
stranded end labeled sense RP3 or end labeled anti-sense RP3.
with the sequence of a cDNA encoding the Y-box binding protein
YB-1 (7), where a few sequence differences were observed. DNA
binding of YB-1 is considered as being sequence specific because
a mutation of the CC AAT element present in the Y-box to a CCC-
AG motif abolished binding to IPTG induced YB-1 lambda gtl 1
phage plaques (7). We confirmed sequence specific DNA binding
of the /9-galactosidase-YB-l fusion protein by EMS A competition
analysis with the mutated long Y-box oligonucleotide (7). In this
assay a 100 fold and 500 fold molar excess of unlabeled RP3
oligonucleotide efficiently competed for YB-1 binding (Fig. 1,
lanes 2 and 3). In contrast, however, the long Y-box mutant
oligonucleotide (7) did not compete in 100 fold and 500 fold molar
excess with YB-1 DNA binding (Fig. 1, lanes 4 and 5).
Therefore, we use the term YB-1 for this protein rather than dbpB
because sequence specific DNA binding activity was established
with a Y box motif.
The enhancer of HPV18 consists of two functionally redundant
domains, one of which has been analyzed for DNA:protein
interactions (21). The /3-galactosidase-YB-l fusion protein bound
to HPV18 enhancer oligonucleotide RP3 (21) but not to other
oligonucleotides from this enhancer domain suggesting that one
YB-1 binding site exists in this domain.
YB-1 binds selectively to the sense strand of a YB-1
recognition site from the HPV18 enhancer
We have observed in binding site blotting experiments using a
variety of synthetic binding sites that some nuclear proteins bound
to double as well as to single stranded recognition sites. We
sought to determine whether YB-1 fusion protein would also bind
to single stranded recognition sites in HPV18 enhancer
oligonucleotide RP3. Expression of clone N4 was induced for
1 hr with IPTG, the fusion protein size fractionated on a
polyacrylamide gel and transferred to nitrocellulose. The
membranes were probed with double stranded RP3 (Fig. 2A),
single stranded RP3 sense strand and the RP3 anti-sense strand
(Fig. 2B). RP3 double strand and sense strand bound to YB-1
fusion protein, in contrast, no binding was detected using the
anti-sense strand. In this experiment equal amounts of fusion
Fig. 3. Identification of a 42kD nuclear YB-1 protein in Hela cells and flbroblasts.
(A) Binding site blot of nuclear extracts made from Hela cells and CgB cells
using end labeled RP3. Nuclear RP3 binding proteins p92 and YB-1 are indicated.
(B) Detection of a nuclear 42kD protein with a peptide antiserum selected from
the YB-1 sequence RQPREDGNEEDKEN. Hela and fibroblast cytoplasms (Q
and nuclear (N) extracts were analyzed by immunoblotting with a second antibody
coupled to alkaline phosphatase. The molecular weights of I4C labeled protein
size markers arc indicated.
protein were run in parallel on the same gel and the nitrocellulose
membrane was cut after transfer prior to incubation with sense
and anti-sense oligonucleotides. A similar result has been reported
for estrogen receptor DNA binding activities were the coding
or sense strand of the estrogen responsive element (ERE) binds
the estrogen receptor with 60 fold higher affinity than the double
stranded ERE and the anti-sense ERE shows no estrogen receptor
binding activity (35).
Identification of a 42kD nuclear YB-1 protein in HeLa cells
and flbroblasts
A synthetic peptide approach was initiated aimed at identifying
YB-1 protein in HeLa cells with the help of an anti YB-1
antiserum (24). This approach is based on the selection of
antigenic regions of YB-1 protein primary sequence using the
computer program ANTIGEN. The program ANTIGEN
identifies the hydrophilicity of proteins. It is assumed that high
hydrophilicity corresponds to high antigenicity. YB-1 protein
displayed one region of very high hydrophilicity which was
selected for peptide synthesis. We synthesized the peptide
RQPREDGNEEDKEN from this region. The peptide was
coupled to keyhole lympett hemocyanine (KLH) and rabbits were
immunized. In binding site blots HPV18 enhancer oligonucleotide
RP3 containing the YB-1 site binds to a protein with a molecular
weight of 92kD which is a novel octamer binding factor (21)
and to two additional proteins p50 and p42 (Fig. 3A). We
analyzed nuclear and cytoplasmic extracts of Hela cells and
fibroblasts in immunoblots using the anti-peptide antiserum in
combination with a second antibody coupled to alkaline
phosphatase. A 42kD protein was recognized by the anti peptide
serum in nuclear extracts of Hela cells and human fibroblasts
(Fig. 3B). Therefore the 42kD protein which was detected by
binding site blotting (Fig. 3A) corresponds most likely to YB-1
protein indicating that YB-1 protein has an apparent molecular
weight of 42kD. In cell extracts from tissue culture cells YB-1
protein was exclusively localized to the nucleus (Fig. 3B).
Preimmune serum did not react with a 42kD protein (24).
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Fig. 4. Tissue restricted expression of the Yb-1 gene in a 24 week old human
fetus. Northern hybridization of total RNAs (5 ng) isolated from different tissues
indicated on top of each lane. Brain RNA was from the cerebrum. Adult kidney
RNA was from a kidney of a 24 year old male. For RNA concentration control
the blot was hybridized to a human /3-actin probe.
Differential expression of the Yb-1 gene in organs and tissues
of a 24 week old human fetus
Transcription factors and sequence specific DNA binding proteins
can be divided into two groups, the first beeing the group of
ubiquitously occurring proteins and the second beeing those with
a restricted pattern of expression or a cell type specific expression.
We sought to establish whether Yb-1 gene expression is regulated
in a tissue restricted manner or whether YB-1 is a ubiquitous
factor. In order to clarify this issue we have extracted RNAs from
fourteen different tissues of a 24 week old human fetus and
determined Yb-1 gene transcription by Northern hybridization
(Fig. 4). High levels of YB-1 mRNA were present in six different
tissues: cerebrum, heart, muscle, adrenal gland, lung and liver.
Low levels of YB-1 mRNA were detected in four different
tissues: kidney, bone marow, spleen and thymus. In four
additional tissues: bladder, testis, stomach and pancreas, the YB-1
gene was either not transcribed or at very low levels which could
not be detected by Northern hybridization. Further experiments
will be necessary to determine whether the Yb-1 gene is silent
in the latter four tissues. In adult human kidney YB-1 mRNA
was present in low amounts (Fig. 4). The Yb-1 gene is also
expressed in human placenta and B-cells because YB-1 cDNA
clones have been be isolated from a human placenta and a B-cell
cDNA expression library (7, 8). In tissue culture cells YB-1
protein was present in Hela and in human fibroblasts (Fig. 3B).
In different cell lines from T-cells, B-cells and monocytes Yb-1
gene expression was observed (7). We conclude that Yb-1 gene
expression is not ubiquitous and that the levels of transcripts vary
considerably in different tissues.
The Yb-1 gene is a member of a dispersed gene family
The mouse chromosomal locations of four Yb-1 related genes
were determined by interspecific backcross analysis using
Fig. 5. Linkage maps showing the chromosomal locations of four Yb-1 loci in
the mouse genome. The Yb-1 loci were mapped by interspecific backcross analysis.
The number of recombinant N2 animals over the total number of N2 animals
typed plus the recombination frequencies, expressed as genetic distance in
centimorgans ( + / - one standard error), is shown for each pair of loci on the
left of the chromosome maps. Where no recombinants were found between loci
the 95% confidence limit of the recombination distance is given in parentheses.
The positions of loci in human chromosomes are shown to the right of the
chromosome maps.
progeny derived from matings of ((C57BL/6JxAfits spretus)
FiXC57bL/6J) mice. This interspecific backcross mapping
panel has been typed for over 800 loci that are well distributed
among all the autosomes as well as the X chromosome (25).
C57BL/6J and M. spretus DNAs were digested with several
enzymes and analyzed by Southern blot hybridization for
informative restriction fragment length polymorphisms (RFLP's)
using the YB-1 probe. M. spretus-spec'ific polymorphisms were
followed in these studies since the interspecific backcross was
to C57BL/6J and C57BL/6J-specific polymorphisms could thus
only be typed by hybridzation intensity. SphI digestion generated
six major fragments in M. spretus DNA of 7.2, 6.2, 5.2, 3.7,
3.6 and 2.7 kb, five of which (6.2, 5.2, 3.7, 3.6 and 2.7 kb)
could be followed in backcross mice. The strain distribution
pattern (SDP) of each RFLP in the interspecific backcross mice
was then determined and used to position the YB-1 related
sequences on the interspecific map (Fig. 5).
The 6.2 kb M. spretus-specific fragment mapped to mouse
chromosome 9 and defined the Yb-la locus, which is 1.6 cM
proximal of Thy-1. The 5.2 kb fragment (Yb-lb) was placed on
chromosome 8 and did not recombine with Ecad. No
recombinants were detected among the two loci in 130 animals
suggesting that they are within 2.3 cM of each other (upper 95%
confidence interval). The Yb-lc locus, characterized by the 3.7
and 3.6 kb SphI fragments, was located on chromosome 7. Yb-lc
did not recombine with Gpi-1 in 132 animals typed for both loci,
suggesting the 2 loci are within 2.2 cM of each other. The 2.7
kb SphI fragment defined Yb-1 d and was located on chromosome
3 (Fig. 5). Yb-ld did not recombine with Fgfb in 159 animals
typed for both loci suggesting that the 2 loci are within 1.9 cM
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of each other. These studies suggest there are at least four loci
in the mouse that are related to YB-1 sequences. It remains to
be determined whether these loci correspond to functional genes
or pseudogenes.
DISCUSSION
YB-1 is a sequence specific DNA binding protein (7) because
a mutation of the core CCAAT to a CCCAG motif in the Y-box
element abolished YB-1 binding activity (7), which was
confirmed by EMSA competition analysis (Fig. 1, lanes 4 and
5). We have found that YB-1 selectively bound to the sense strand
of HPV18 enhancer oligonucleotide RP3. This kind of binding
specificity was previously described for estrogen receptor binding
to the estrogen responsive element (35). DNA dependent RNA
polymerases II and HI require auxiliary proteins for accurate and
selective initiation of transcription (36, 37, 38). Some of these
factors are sequence specific DNA binding proteins and
transcription factors. The function of YB-1 as a transcription
factor remains to be established, in Xenopus, however, highly
similar Y-box (CCAAT) binding proteins exist (FRG Yl and
FRG Y2) which are transcriptional activators (39). The double
strand binding specificity of YB-1 may be needed to concentrate
YB-1 at a promoter or enhancer and the single strand binding
specificity would keep YB-1 DNA bound during transitory strand
separation in an initiation complex.
The open reading frame of full length YB-1 cDNA is 972 (8)
bases long and the predicted molecular weight of YB-1 protein
is 35.6kD. Antiserum which was raised against a synthetic YB-1
peptide, however, detected a 42kD nuclear protein in
immunobloting experiments. Therefore we conclude that cellular
YB-1 protein is a 42kD nuclear protein. Some proteins have
higher molecular weights in polyacrylamide gels than that
predicted by the primary amino acid sequence. One reason for
this difference could be the occurrence of postranslational protein
modifications such as phosphorylation or glycosylation.
Sequence specific DNA binding proteins and transcription
factors can be ubiquitous, tissue restricted or cell type specific.
Examples for cell type specific regulatory factors are the Oct-2
protein from B-cells (40) and Myo Dl which is muscle specific
(41). Examples of transcription factors which are present in
multiple tissues are: AP2, JUNB, JUNC, C/EBP. NFY-A, NFY-
B and SP1 (10, 42, 43, 44). Yb-1 gene expression was high in
heart, cerebrum, muscle, adrenal gland, liver and lung. As the
Yb-1 gene is part of a family of related genes, it is possible that
the observed expression pattern is not due to the activity of a
single gene. To sort out the roles of all these factors in
transcriptional regulation and during development it is necessary
to define their individual fields of action in the organism and
identify the target genes that they regulate within those fields.
A first step in this analysis is to determine the expression of the
genes encoding these factors in many tissues of an organism. The
Yb-1 gene may negatively regulate HLA DR alpha gene
expression because its level of expression is inversely correlated
with the expression of the HLA DR alpha gene (7). The
occurrence of CCAAT motifs and Y-box motifs in many gene
control regions suggests that Y-box transcription factors may
regulate tissue-specific gene expression in completely different
contexts (39).
The Yb-1 gene belongs to a dispersed gene family
We have determined by interspecific backcross mapping that
YB-1 related sequences are present on four different mouse
chromosomes. There was an essentially invariant Sphlband (7.2
kb in Spretus; 7.4 kb in B6) that could not be typed. This fragment
might represent yet another Yb-1 related gene. We have compared
our interspecific map in which the Yb-1 related genes have been
placed with a composite mouse linkage map that includes many
uncloned mutations compiled by M.T.Davisson, T.H.Roderick,
A.L.Hillyard, and D.P.Doolittle and provided from GBASE (a
computerized database maintained at the Jackson Laboratory, Bar
Harbour, ME) and find that several mouse mutations lie in the
vicinity of some of these loci (not shown). Assuming these loci
encode functional genes, it will be of interest to determine the
mouse developmental and tissue specific expression patterns of
these genes and whether any of the mutations are candidates for
alterations in a Yb-1 related gene. Finally, it is often possible
to predict where a gene will map in humans by determining its
location in mouse. Based upon the positions of the Yb-1 related
genes on the interspecific map we can predict that Yb-la will
likely reside on human chromosome llq, Yb-lb on I6q, Yb-lc
on 19q and Yb-ld on 4q.
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